International Dysferlinopathy Registry (LGMD2B)
A registry for patients affected with a dysferlinopathy is under development in collaboration with the Jain Foundation and will be launched later in 2012. This International Dysferlinopathy Registry is designed for patients with the most frequent clinical presentations called Limb Girdle Muscular Dystrophy type 2B (LGMD2B) and Miyoshi myopathy, but also for patients with all other clinical presentations related to genetic defects in the gene called "dysferlin".
For the time being, patients with LGMD2B/Miyoshi myopathy may be interested in registering with the Jain Foundation Registry.

